Conference
Exploratory phase II evaluation of cabozantinib in recurrent/metastatic uterine carcinosarcoma (CS): A study of the Princess Margaret, Chicago, and California phase II consortia.
Abstract
5587
Authors
Mandilaras V; Dhani NC; Tan Q; Jain A; Johnston C; Hirte HW; Tonkin KS; Cristea MC; Matsuo K; Butler MO
Volume
35
Pagination
pp. 5587-5587
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2017
DOI
10.1200/jco.2017.35.15_suppl.5587
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X